Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 |
filingDate |
1996-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c79bd57d8309ce1e940f73d65a6e7c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd5eff4af85efe9fd5174533f2686383 |
publicationDate |
1996-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9637231-A1 |
titleOfInvention |
Skin permeation enhancer compositions using acyl lactylates |
abstract |
The present invention is directed to the transdermal administration of a drug together with a suitable amount of an acyl lactylate permeation enhancer. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in drug-and permeation enhancer-transmitting relation with a skin site. The matrix contains sufficient amounts of an acyl lactylate permeation enhancer and drug, in combination, to continuously administer drug to the systemic circulation of a patient at a therapeutically effective rate. The invention is also directed to compositions and methods for transdermal administration of a drug together with an acyl lactylate permeation enhancer, alone or in combination with other enhancers. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9932153-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100425233-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6267984-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007011763-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7018649-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5952000-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5912009-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1328273-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1328273-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6960353-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6512010-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7011844-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6203817-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007011763-A3 |
priorityDate |
1995-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |